Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.08 - $2.49 $259,376 - $310,503
-124,700 Reduced 25.73%
360,000 $792,000
Q2 2024

Aug 14, 2024

BUY
$2.27 - $3.02 $1.1 Million - $1.46 Million
484,700 New
484,700 $1.13 Million
Q1 2023

May 15, 2023

SELL
$1.87 - $2.6 $2,431 - $3,380
-1,300 Reduced 40.63%
1,900 $3,000
Q4 2022

Feb 14, 2023

SELL
$2.49 - $3.5 $2,241 - $3,150
-900 Reduced 21.95%
3,200 $8,000
Q3 2022

Nov 14, 2022

BUY
$2.82 - $3.58 $1,974 - $2,506
700 Added 20.59%
4,100 $12,000
Q2 2022

Aug 08, 2022

SELL
$2.59 - $3.92 $211,085 - $319,480
-81,500 Reduced 96.0%
3,400 $10,000
Q1 2022

May 16, 2022

BUY
$3.0 - $4.25 $254,700 - $360,825
84,900 New
84,900 $330,000
Q4 2021

Feb 14, 2022

SELL
$3.85 - $6.71 $58,905 - $102,663
-15,300 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$5.6 - $8.58 $10,640 - $16,302
-1,900 Reduced 11.05%
15,300 $87,000
Q2 2021

Aug 16, 2021

BUY
$7.16 - $9.41 $92,364 - $121,389
12,900 Added 300.0%
17,200 $148,000
Q1 2021

May 17, 2021

BUY
$7.52 - $15.55 $32,335 - $66,865
4,300 New
4,300 $41,000
Q4 2020

Feb 16, 2021

SELL
$5.0 - $8.85 $399,000 - $706,230
-79,800 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$4.96 - $7.08 $286,688 - $409,224
57,800 Added 262.73%
79,800 $400,000
Q2 2020

Aug 14, 2020

BUY
$4.84 - $8.02 $106,480 - $176,440
22,000 New
22,000 $132,000
Q1 2020

May 15, 2020

SELL
$4.52 - $8.55 $224,191 - $424,080
-49,600 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$6.14 - $9.3 $248,670 - $376,650
-40,500 Reduced 44.95%
49,600 $380,000
Q3 2019

Nov 14, 2019

SELL
$9.05 - $16.02 $47,060 - $83,304
-5,200 Reduced 5.46%
90,100 $815,000
Q2 2019

Aug 14, 2019

BUY
$13.58 - $18.61 $1.29 Million - $1.77 Million
95,300 New
95,300 $1.52 Million

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $760M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.